Skip to Main Content
TRC_PL_NEW
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Student Resources
    • Faculty Resources
    • Journal Club
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Antidepressants
    • Contraceptives
    • Diabetes Drugs
    • Do Not Crush List
    • First Time Generics
    • New Drugs
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

NatMed Pro, the largest natural medicines database, just got a major upgrade! With faster performance, a redesigned interface, and improved navigation, it's easier than ever to find the evidence-based answer you need. Explore Now
New Podcast CE Alert: "Meds for Alzheimer Dementia" is now available! Listen for FREE now. Subscribers can earn CE credits just for listening and passing a short quiz.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Resources
  5. Charts

Charts

  • Diabetes (920)
  • Endocrinology (11)
  • Hyperglycemia (40)
  • Hypoglycemia (19)
  • Other (32)
  • Prediabetes (5)
  • Resources (278)
    • Charts (57)
    • Guidelines (81)
    • Letters (3)
    • Natural Medicines / Supplements (4)
    • Patient Education (12)
    • PL Voices (159)
    • Quality Measures (40)
  • Thyroid Disorders (64)
46 - 57 of 57 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Commentary: Is Lantus Associated With An Increased Risk of Cancer? August 2009
Other: Sample Collaborative Practice Agreement August 2009
Chart: Collaborative Drug Therapy Management (CDTM) August 2009
Commentary: Selecting a Sulfonylurea April 2009
Commentary: How Much Insulin Is Too Much? January 2009
Guideline: 2008 ADA Consensus Statement on Management of Hyperglycemia in Type 2 Diabetes November 2008
Commentary: Insulin Use in Patients with Type 2 Diabetes November 2008
Guideline: ADA Position Statement on Standards of Medical Care in Diabetes - 2008 November 2008
Commentary: Exubera Off the Market November 2007
Other: Info for Healthcare Providers About the Discontinuation of Exubera November 2007
Commentary: Avandia (Rosiglitazone) and the Risk of Myocardial Infarction July 2007
Commentary: Avandia (Rosiglitazone) and the Risk of Myocardial Infarction June 2007
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved